These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37669322)

  • 1. Cross-seeding by prion protein inactivates TDP-43.
    Polido SA; Stuani C; Voigt A; Banik P; Kamps J; Bader V; Grover P; Krause LJ; Zerr I; Matschke J; Glatzel M; Winklhofer KF; Buratti E; Tatzelt J
    Brain; 2024 Jan; 147(1):240-254. PubMed ID: 37669322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of variant Creutzfeldt-Jakob disease prions in vivo by the Hsp70 disaggregase system.
    Thackray AM; Lam B; McNulty EE; Nalls AV; Mathiason CK; Magadi SS; Jackson WS; Andréoletti O; Marrero-Winkens C; Schätzl H; Bujdoso R
    Brain; 2022 Sep; 145(9):3236-3249. PubMed ID: 35446941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
    Ma J; Zhang J; Yan R
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology of Animal Prion Diseases.
    Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
    Mishra RS; Bose S; Gu Y; Li R; Singh N
    J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of the prion protein to the cytosol: mechanisms and consequences.
    Miesbauer M; Rambold AS; Winklhofer KF; Tatzelt J
    Curr Issues Mol Biol; 2010; 12(2):109-18. PubMed ID: 19767654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.
    Isaacs AM; Powell C; Webb TE; Linehan JM; Collinge J; Brandner S
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):446-56. PubMed ID: 18657254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturally occurring variant of the human prion protein completely prevents prion disease.
    Asante EA; Smidak M; Grimshaw A; Houghton R; Tomlinson A; Jeelani A; Jakubcova T; Hamdan S; Richard-Londt A; Linehan JM; Brandner S; Alpers M; Whitfield J; Mead S; Wadsworth JD; Collinge J
    Nature; 2015 Jun; 522(7557):478-81. PubMed ID: 26061765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular aspects of prion replication in vitro.
    Grassmann A; Wolf H; Hofmann J; Graham J; Vorberg I
    Viruses; 2013 Jan; 5(1):374-405. PubMed ID: 23340381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prions and their biology].
    Gasset M; Westaway D
    Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP).
    Gielnik M; Zhukova L; Zhukov I; Gräslund A; Kozak M; Wärmländer S
    Acta Biochim Pol; 2022 Feb; 69(1):257-261. PubMed ID: 35143147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.